NJ Bio Awarded as The Best Contract Research Provider (CRO) at the 8th Annual World ADC Awards, 2021

Princeton, NJ – NJ Biopharmaceutical (d/b/a NJ Bio), a global provider of outsourced integrated chemistry and biology services to clients in the pharmaceutical and biotechnology industries was awarded the Best Contract Research Provider Award, 2021 at the 8th Annual World ADC Awards on October 12th, 2021.

The Annual World ADC Awards were created to recognize the extraordinary endeavors, teamwork, and commercial acumen that has propelled the field to the forefront of cancer research today. “We are humbled and honored that our clients have shown their unwavering support for our dedication to their ADC programs even thru a very challenging year. I also want to thank my NJ Bio team for their laser-sharp focus on delivery, high-quality services for bioconjugations & ADCs, their expertise in navigating challenging projects. Thanks to our veteran SAB members that create great value for our clients through their expert advice and tremendous experience in this field”, commented Dr Naresh Jain, Founder, President, and CEO of NJ Bio.

NJ Bio’s rapid growth and expanded facility & services, educational items in our website, and cost-effective payload linker synthesis using our blended FTE models have enabled many startups and established clients to move from ideation to tangible proof-of-concept, helped them gain more resources & funding for their programs. Over the past three years, NJ Bio has proven that their clients are their core focus, and as a family-owned business they treat all clients like family.


————-For more news and events, click here